Signals, Powered By EquityPandit
About Sai Life Sciences Ltd IPO
Sai Life Sciences Ltd is gearing up to launch its Rs 3,042.62 crore IPO. This IPO subscription is an amalgamation of a fresh issue of Rs 950 crore (1.73 crore shares) and an offer-for-sale of Rs 2,092.62 crore (3.81 crore shares). The company is gearing up to list on both the BSE and NSE.
Retail investors must make a minimum investment of Rs 14,823 to participate. Small NII investors need to invest at least Rs 207,522 for 378 shares, equivalent to 14 lots. Large NII investors need a minimum investment of Rs 1,007,964 for 1,836 shares, which is 68 lots.
Kfin Technologies Ltd has been appointed as the official registrar for this offering. Kotak Mahindra Capital Company Ltd, Jefferies India Pvt Ltd, Morgan Stanley India Company Pvt Ltd and IIFL Securities Ltd are the book running lead managers in this IPO.
Sai Life Sciences Ltd IPO Latest GMP:
The most recent GMP of the IPO is Rs 42, as of 11th December, 2024 11:01 AM. The IPO has a price band of Rs 549. The estimated listing price for Sai Life Sciences Ltd is Rs 591, reflecting a potential gain of 7.65% per share.
For the IPO, the Retail Subject to Sauda is Rs 900, and the Small HNI Subject to Sauda is Rs 12,600. The GMP ranges from a low of Rs 22 to a high of Rs 42.
Sai Life Sciences Ltd IPO Details
| Sai Life Sciences Ltd IPO Opening Date and Closing Date | 11th December to 13th December |
| Face Value | Rs 1 per share |
| Price Band | Rs 522 to Rs 549 per share |
| Lot Size | 27 Shares |
| Total Issue Size | 55,421,123 shares (aggregating up to Rs 3,042.62 Cr) |
| Fresh Issue | 17,304,189 shares (aggregating up to Rs 950 Cr) |
| Offer for Sale | 38,116,934 shares (aggregating up to Rs 2,092.62 Cr) |
| Issue Type | Book-Built Type Issue |
| Listing At | NSE, BSE |
| Shareholding Pre-Issue | 190,685,340 |
| Shareholding Post Issue | 207,989,529 |
| Basis of Allotment | Monday, 16th December, 2024 |
| Refund Initiation | Tuesday, 17th December, 2024 |
| Credit of Shares in Demat | Tuesday, 17th December, 2024 |
| Listing Date | Wednesday, 18th December, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on 13th December, 2024 |
| Draft Red Herring Prospectus | Link |
| Red Herring Prospectus | Link |
Sai Life Sciences Ltd Company Details
- Sai Life Sciences Ltd, founded in January 1999, specialises in researching, developing, and manufacturing small-molecule new chemical entities. The company provides customised services to biotech firms and global pharmaceutical companies.
- In FY 2024, Sai Life Sciences provided services to over 280 pharmaceutical companies, including more than 230 in September 2024.
- The company worked with 18 of the top 25 pharmaceutical companies by revenue in 2023.
- Services were offered across countries such as the US, UK, Europe, and Japan.
- The business development team has 16 professionals, with six in the US, nine in the UK and Europe, and one in Japan.
- The company offers capabilities in CMC/CDMO and CRO services, including integrated discovery across biology, chemistry, and drug metabolism.
- As of 30th September, 2024, the company had 2,353 scientific staff, including 302 Ph.D.s and 1,475 master’s degrees.
- The total employee count was 3,135, covering the CRDMO value chain.
Sai Life Sciences Ltd IPO Lot Size, Shares, And Their Value:
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 27 | Rs 14,823 |
| Retail (Max) | 13 | 351 | Rs 192,699 |
| S-HNI (Min) | 14 | 378 | Rs 207,522 |
| S-HNI (Max) | 67 | 1,809 | Rs 993,141 |
| B-HNI (Min) | 68 | 1,836 | Rs 1,007,964 |
Investor categories and Sai Life Sciences Ltd shares offered:
| Investor Category | Shares Offered |
| Anchor Investor Shares Offered | 1,66,26,336 (30%) |
| QIB Shares Offered | 1,10,84,225 (20%) |
| Retail Shares Offered | 1,93,97,392 (35%) |
| NII (HNI) Shares Offered | 83,13,168 (15%) |
Sai Life Sciences Ltd Company Performance:
For the period ended on 31st March, 2024 & 31st March, 2023:
| Periods Ended | 31st Mar, 2024 | 31st Mar, 2023 |
| Assets | Rs 2,275.14 Cr. | Rs 2,186.65 Cr. |
| Revenue | Rs 1,494.27 Cr. | Rs 1,245.11 Cr. |
| Profit After Tax | Rs 82.81 Cr. | Rs 9.99 Cr. |
| Net Worth | Rs 974.34 Cr. | Rs 887.29 Cr. |
| Reserves and Supplies | Rs 953.99 Cr. | Rs 867.43 Cr. |
| Total Borrowing | Rs 710.16 Cr. | Rs 699.23 Cr. |
Sai Life Sciences Ltd IPO: Worth Investing?
Financial Performance:
Revenue: The company generated Rs 693.35 crore in revenue during the period ended on 30th September, 2024.
Profit After Tax (PAT): The company earned a profit of Rs 28.01 crore after deducting taxes.
Net Worth: The company’s net worth, which represents the total value of the company’s assets minus its liabilities, is Rs 1,044.75 crore.
Financial Position:
Assets: The company’s total assets amounted to Rs 2,476.78 crore.
Reserves and Surplus: The company has accumulated reserves and surplus of Rs 1,025.44 crore.
Sai Life Sciences Ltd Key Performance Indicators (KPI) and their values:
The market capitalisation of Sai Life Sciences Ltd IPO is Rs 11,418.63 crore. As of 31st March, KPI and their values are:
| KPI | Values |
| Return on Equity (ROE) | 11.79% |
| Return on Capital Employed (ROCE) | 15.96% |
| Return on Net Worth (RoNW) | 8.13% |
| Price to Book Value (P/BV) | 10.18 |
| PAT Margin (%) | 5.65 |
Objectives of Sai Life Sciences Ltd IPO
The company plans to use the Net Proceeds for the following purposes:
- Repayment or prepayment of all or part of its outstanding borrowings.
- General corporate purposes.
Key Risks of Investing in Sai Life Sciences Ltd IPO
- Strict global regulatory norms can affect operations.
- Revenue concentration from key clients poses a risk.
- Faces competition from global and regional CRAMS players.
- Global economic conditions may influence outsourcing trends.
- Fluctuating input costs could impact profitability.
Some Frequently Asked Questions (FAQs)
What is the price band of Sai Life Sciences IPO?
Price band has been fixed at Rs 522 and Rs 549 per share.
What is the retail investor quota of Sai Life Sciences Ltd IPO?
A maximum of 35% shares shall go to the retail investors.
What is the lot size and share distribution for High Net-Worth Individuals (HNIs)?
The lot size for HNIs is 14 lots, with a total of 378 shares allocated.
How can I apply for Sai Life Sciences Initial Public Offer?
You can apply through your demat account, banking channels, or other financial institutions during the IPO period.
When is the Last Date of IPO subscription for Sai Life Sciences Ltd?
The cut-off time is 5 PM on 13th December, 2024, but many brokers close applications earlier, typically between 1-3 PM.
Unlock profitable opportunities every day! Unicorn Signals provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Unicorn Signals and start winning now!
